Tonix Pharmaceuticals Holding Corpis A Clinical Stage Biopharmaceutical Company Based In New Yorkwith Additional Operations In Chathamnew Jerseythe Company Is Dedicated To Developing Innovative Therapies And Vaccines Aimed At Preventing And Treating Central Nervous System Disorders And Other Serious Health Conditions Founded In 2011 Through A Reverse Mergertonix Became Publicly Traded On The Nasdaq In 2013Its Product Pipeline Includes Treatments For Various Conditionssuch As Tnx 102 Sl For Fibromyalgiatnx 1900 For Migraine Preventionand Tnx 601 For Depressionthe Company Is Also Developing Vaccine Candidates For Smallpoxmonkeypoxand Covid 19Along With Treatments For Conditions Like Cocaine Intoxication And Gastric Cancer Led By Drseth Ledermantonix Pharmaceuticals Focuses On Advancing Its Research And Development Efforts To Create Safer And More Effective Medicinesthe Company Is Committed To Addressing Unmet Medical Needs In Areas Such As Post Traumatic Stress Disorder And Rare Diseases
No conferences found for this company.
| Company Name | Toniq Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
